ADVISORY, Nov. 28, 2016 (GLOBE NEWSWIRE) --
What:
OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in point-of-care diagnostic tests and specimen collection
devices, will visit the Nasdaq MarketSite in Times Square, to raise awareness about the issues surrounding HIV and AIDS for World
AIDS Day, observed on December 1, 2016.
In honor of the occasion, Doug Michels, President and CEO of OraSure Technologies and Debra Messing, Global Health
Ambassador for Population Services International (PSI), will ring the Opening Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Tuesday, November 29, 2016 – 9:15 a.m. to 9:30 a.m. ET
OraSure Media Contact:
Ron Ticho
610-360-0205
rticho@orasure.com
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please
visit our Facebook page:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our Instagram page:
http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our YouTube page:
http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our Tumblr page:
http://nasdaq.tumblr.com/
Webcast:
A live stream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market open of your
choice.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and
collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market,
innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform,
oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid
laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and
academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers.
The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions
to improve and protect their health.
For more information on OraSure Technologies, please visit www.orasure.com.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public
company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and
execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed
companies with a market value of $10.0 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com
-NDAQA-
